Table 5

Lipid and Inflammatory Measures at Week 0 and Week 40

Measurement^†

Week

MD Group

Mean ± SD

Within Group

Δ p-value

Week

FB Group

Mean ± SD

Within Group

Δ p-value

Between Group

Δ p-value

Total

0 (n = 39)

191.2 ± 39.5

p = 0.154

0 (n = 40)

187.5 ± 43.0

p = 0.003

p = 0.632

Cholesterol (mg/dl)

40 (n = 23)

182 ± 32.5

40 (n = 20)

183.0 ± 45

HDL

0 (n = 39)

52.0 ± 16.0

p = 0.509

0 (n = 40)

51.8 ± 18.0

p = 0.029

p = 0.86

(mg/dl)

40 (n = 23)

53.2 ± 12.2

40 (n = 20)

49.6 ± 11.8

LDL

0 (n = 39)

117.3 ± 31.8

p = 0.088

0 (n = 40)

108.8 ± 32.0

p = 0.099

p = 0.811

(mg/dl)

40 (n = 23)

107.1 ± 28.5

40 (n = 20)

104.1 ± 31.1

VLDL

0 (n = 38)

21.9 ± 13.0

p = 0.614

0 (n = 37)

27.9 ± 17.9

p = 0.38

p = 0.648

(mg/dl)

40 (n = 23)

21.7 ± 14.0

40 (n = 20)

29.3 ± 16.4

Triglycerides

0 (n = 39)

109.2 ± 63.7

p = 0.516

0 (n = 40)

134.7 ± 86.8

p = 0.391

p = 0.579

(mg/dl)

40 (n = 23)

107.7 ± 70.1

40 (n = 20)

137.4 ± 101.2

CRP

0 (n = 38)

5.7 ± 4.8

p < 0.0001

0 (n = 39)

7.1 ± 9.4

p = 0.008

p = 0.886

(mg/L)

40 (n = 23)

2.6 ± 2.2

40 (n = 20)

3.5 ± 3.6

ULP

0 (n = 44)

6.1 ± 2.2

p = 0.006

0 (n = 44)

5.5 ± 1.7

p = 0.837

p = 0.038

(micromol/g creatinine)

40 (n = 23)

4.9 ± 2.4

40 (n = 20)

5.4 ± 2.5

Δ = Change from baseline to 40 weeks.

^† = Secondary outcomes.

Davis et al. Nutrition Journal 2010 9:11   doi:10.1186/1475-2891-9-11